Browsing Category
Pharma Industry News
4752 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Elevation Oncology strengthens cancer drug pipeline as cash reserves hit $93m
Elevation Oncology, Inc. has released its financial results for the fourth quarter and full-year 2024, outlining significant progress…
Biocon Biologics strengthens US market presence with Civica insulin deal
As insulin prices remain a pressing concern in the United States, Biocon Biologics collaboration with Civica, Inc. has…
Hoth Therapeutics advances HT-001 as promising therapy for EGFR inhibitor-related skin toxicities
Hoth Therapeutics, Inc. has announced positive findings for HT-001 treatment, positioning it as a potential breakthrough therapy for…
CStone advances CS5001 clinical trial for first-line DLBCL treatment in Australia
CStone Pharmaceuticals has taken a significant step in the development of its ROR1 antibody-drug conjugate with the submission…
Akeso completes patient enrollment for Phase III Cadonilimab trial in high-risk HCC
Akeso, Inc. has announced the completion of patient enrollment for its Phase III cadonilimab trial (COMPASSION-22/AK104-306), marking a…
CStone Pharmaceuticals advances CS2009 clinical trial, targeting multi-billion-dollar immunotherapy market
CStone Pharmaceuticals has officially commenced the Phase I clinical trial for CS2009, a cutting-edge PD-1/VEGF/CTLA-4 trispecific antibody, marking…
Can WuXi Biologics’ new EffiX platform transform microbial expression? Here’s what to know
WuXi Biologics has introduced the EffiX platform, an advanced microbial expression system designed to enhance the production of…
AbbVie to develop amylin analog for obesity treatment in $350m licensing deal with Gubra
AbbVie has taken a significant step into obesity treatment through a licensing agreement with Denmark-based Gubra, a company…
QIAGEN files lawsuit against bioMĂ©rieux to defend QuantiFERON patents and innovation in TB diagnostics
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) has initiated legal proceedings against bioMĂ©rieux S.A. (EPA: BIM) in…
Amgen and AstraZeneca’s Tezspire achieves key milestone in Phase 3 nasal polyps trial
Amgen and AstraZeneca have revealed promising results from the Phase 3 Waypoint trial, demonstrating that Tezspire (tezepelumab-ekko) delivers…